All the molecular mediators (potential targets of RNAi for ARDS) mentioned in the review were based on in vitro and in vivo experiments where the primary endpoint was the systemic reduction in the level of IL-6 and TNF-alpha. Here, IL6 is linked to acute respiratory distress syndrome.